Wall Street’s Key Stock Analysts Research Reports

Wall Street’s Key Stock Analysts Research Reports


Daily HeffX-LTN reviews dozens of  Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is the list for Tuesday, 28 January, as follows:

Amazon.com Inc. (NASDAQ:AMZN) was reiterated as Buy and the target price was raised to 2,300 from 2,100 at Benchmark.The prior consensus target price has risen, but was last seen at 2,181.63.

Antero Midstream Corp. (NYSE:AM) was 6.16 Monday, compared with a 52-wk high of 14.56 and a prior consensus target price of 8.18. Citigroup maintained it as Buy but slashed its target price to 7 from 12.

Clearside Biomedical Inc. (NASDAQ:CLSD) was reiterated as Outperform with a 5 target price at Wedbush, with the firm talking up potential catalysts in Y 2020, starting with a resubmission of Xipere new drug application in Q-2 of Y 2020.

Facebook Inc. (NASDAQ:FB) was reiterated as Buy and the target price was raised to 250 from 240 at Stifel. Its consensus target price is 246.00.

S&P Global Inc. (NYSE:SPGI) was raised to Outperform from Market Perform with a 326 target price at BMO Capital Markets.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

You must be logged in to post comments :